Andrew Baum
Stock Analyst at Citigroup
Total Price Targets
6
Stocks Covered
5
Sectors
Healthcare
Most Recent
Dec 28, 2023
Stocks Covered by Andrew Baum
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | $675.00 | $995.70 | -32.2% | 2 | Dec 28, 2023 |
| PFE | Pfizer Inc. | $57.00 | $26.57 | +114.5% | 1 | Apr 9, 2022 |
| ABBV | AbbVie Inc. | $155.00 | $205.71 | -24.7% | 1 | Jan 29, 2022 |
| MRK | Merck & Co., Inc. | $85.00 | $113.88 | -25.4% | 1 | Nov 29, 2021 |
| BMY | Bristol-Myers Squibb Company | $75.00 | $57.10 | +31.3% | 1 | Oct 25, 2021 |
Recent Activity
- Dec 28, 2023— Set$675.00price target onLLY(Eli Lilly and Company)
- Apr 9, 2022— Set$57.00price target onPFE(Pfizer Inc.)
- Jan 29, 2022— Set$155.00price target onABBV(AbbVie Inc.)
- Dec 7, 2021— Set$265.00price target onLLY(Eli Lilly and Company)
- Nov 29, 2021— Set$85.00price target onMRK(Merck & Co., Inc.)
- Oct 25, 2021— Set$75.00price target onBMY(Bristol-Myers Squibb Company)
Frequently Asked Questions
Who is Andrew Baum?
Andrew Baum is a stock analyst at Citigroup covering 5 stocks primarily in Healthcare. They have issued 6 price targets since Oct 25, 2021.
What stocks does Andrew Baum cover?
Andrew Baum currently covers 5 stocks, including LLY, PFE, ABBV, MRK, BMY.
What is Andrew Baum's latest price target?
Andrew Baum's most recent price target was $675.00 on LLY (Eli Lilly and Company), set on Dec 28, 2023.
What is Andrew Baum's highest price target?
Andrew Baum's highest issued price target is $675.00 on LLY, set on Dec 28, 2023.
More Analysts at Citigroup
Coverage based on publicly published price targets. Not investment advice.